Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/1995
12/20/1995EP0667772A4 Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them.
12/20/1995EP0529032B1 Process for the continuous extraction of peat and apparatus for carrying out the process
12/20/1995EP0462258B1 Ureido derivatives of poly-4-amino-2-carboxy-1-methyl compounds
12/20/1995EP0180581B2 Drug preparations of reduced toxicity
12/20/1995CN1113518A A novel peptide related to human programmed cell death and DNA encoding it
12/20/1995CN1113490A New acronycine analogues, a process for their preparation and pharmaceutical compositions containing them
12/20/1995CN1113434A Drug
12/19/1995US5476966 Method for depletion of glutathione
12/19/1995US5476954 Condensing hydroxyl protected taxane derivative with oxazolidine derivative, decyclizing in acid medium, reacting butoxycarbonyl or benzoyl radical with amine, deprotecting, isolating, purifying product
12/19/1995US5476932 Selective hydrolysis or deacylating of sugar part of acylcytidine compound
12/19/1995US5476930 Thiophosphorylacetylamino linkage; reacting a thiophosphate compound with a bromoacetylamino compound
12/19/1995US5476866 Isoxazoles
12/19/1995US5476860 Diaromatic compounds derived from a salicylic unit and their use in human and veterinary medicine and in cosmetics
12/19/1995US5476855 Enzyme inhibitors, their synthesis and methods for use
12/19/1995US5476851 Pyrazolo[3,4-g]quinoxaline compounds which inhibit PDGF receptor protein tyrosine kinase
12/19/1995US5476847 Treating cardiovascular, gastrointestinal, urogenital disorders
12/19/1995CA2069869C Uncharged morpholino-based polymers having phosphorous-containing chiral intersubunit linkages
12/19/1995CA1337767C Indolocarbazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
12/19/1995CA1337763C Staurosporine derivatives with substituted methylamino nitrogen
12/19/1995CA1337760C Antibacterial and antitumor agents ll-e33288e-i and ll-e33288e-br, with processes and intermediates for producing said agents
12/19/1995CA1337754C Red-shifted phthalocyanine and tetrabenztriazaporphyrin reagents
12/15/1995CA2151635A1 Antitumoral Compounds
12/15/1995CA2150994A1 P53as protein and antibody therefor
12/14/1995WO1995033855A1 Isolated nucleic acid molecule which codes for a tumor rejection antigen precursor, and uses thereof
12/14/1995WO1995033772A1 Flt4 receptor tyrosine kinase and its use in diagnosis and therapy
12/14/1995WO1995033771A1 MONOCLONAL ANTIBODY ACTIVE AGAINST CD44v6
12/14/1995WO1995033765A1 Conformationally constrained backbone cyclized peptide analog
12/14/1995WO1995033751A1 Bicycling lactam inhibitor of interleukin-1-beta converting enzyme
12/14/1995WO1995033750A1 Corticotropin releasing factor antagonists
12/14/1995WO1995033744A1 Tachykinin (nk1) receptor antagonists
12/14/1995WO1995033739A1 New taxoids, preparation thereof and phamaceutical compositions containing them
12/14/1995WO1995033737A1 Taxoids, preparation and pharmaceutical compositions containing them
12/14/1995WO1995033736A1 New taxoids, preparation thereof and pharmaceutical compositions containing them
12/14/1995WO1995033709A1 Hydroxylamine derivatives and their use as metalloproteinase inhibiting agents
12/14/1995WO1995033495A1 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy
12/14/1995WO1995033491A1 Biotin compounds for targetting tumors and sites of infection
12/14/1995WO1995033461A1 Anti-inflammatory compounds
12/14/1995WO1995033454A1 Uterine fibroid treatment
12/14/1995CA2192384A1 Biotin compounds for targetting tumors and sites of infection
12/14/1995CA2192370A1 Monoclonal antibody active against cd44v6
12/14/1995CA2192305A1 Conformationally constrained backbone cyclized peptide analogs
12/14/1995CA2192061A1 Uterine fibroid treatment
12/14/1995CA2191728A1 Isolated nucleic acid molecule which codes for a tumor rejection antigen precursor, and uses thereof
12/14/1995CA2190657A1 New taxoids, preparation thereof and phamaceutical compositions containing them
12/14/1995CA2190651A1 New taxoids, preparation thereof and pharmaceutical compositions containing them
12/14/1995CA2187531A1 Tachykinin (nk1) receptor antagonists
12/13/1995EP0686642A2 Modified guanidino and amidino thrombin inhibitors
12/13/1995EP0686641A1 2'-deoxy-5-fluorouridine derivative, pharmaceutically acceptable salt thereof, process for producing the same, and antitumor drug
12/13/1995EP0686640A1 Platinum complex and malignant tumor treating drug containing the same
12/13/1995EP0686627A2 Substituted perfluoroalkylguanidines, process for their preparation, their use as medicine or diagnostic as well as medicines containing them
12/13/1995EP0686260A1 Human carcinoma antigen (hca), hca antibodies, hca immunoassays, methods of imaging and therapy
12/13/1995EP0686156A1 Pyrazolitriazines with interleukin-1 and tumour necrosis factor inhibitory activity
12/13/1995EP0686143A1 Unsaturate amino compounds for use as anticancer and antiprotozoic agent
12/13/1995EP0686038A1 Combination cisplatin/tamoxifen therapy for human cancers
12/13/1995EP0470221B1 New arylethenylene derivatives and process for their preparation
12/13/1995EP0419535B1 Platinum-polymer complexes and their use as antitumor agents
12/13/1995CN1113390A Defective adenovirus vectors and use thereof in gene therapy
12/13/1995CN1113384A Process for the preparation of 9-amino camptothecin
12/12/1995US5475113 Tetrahydronaphthyl and thiazole, oxazole or imidazole substituted ethene derivatives having retinoid-like activity, reduced skin toxicity and reduced teratogenecity
12/12/1995US5475106 Agonist for cholecystokinin and gastrin receptors; nervous system, gastrointestinal disorders
12/12/1995US5475104 Useful in magnetic resonance imaging; detection tumors, cancer cells; transition and lanthanide metals
12/12/1995US5475092 Deliver cytotoxic drugs to specific cell population in targeted fashion
12/12/1995US5475087 Polypeptides
12/12/1995US5475032 Treating strokes
12/12/1995US5475017 Diaryl-substituted heterocyclic compounds, drugs and cosmetics obtained therefrom
12/12/1995US5475011 Administering novel taxanes for treating ovarian, breast, non-small cell lung and colon cancers
12/12/1995US5475006 Mixed oxidation products which cannot form Vitamin A
12/12/1995US5475001 Receptor tyrosine kinase inhibitory; anticarcinogenic agent
12/12/1995US5474995 Phenyl heterocycles as cox-2 inhibitors
12/12/1995US5474981 Use of the cytokine IP-10 as an anti-tumor agent
12/12/1995US5474928 Arginine deiminase from a Mycoplasma arginini strain
12/12/1995US5474904 Methods of imaging cancer cells using modified C-reactive protein
12/12/1995US5474771 Inhibits T cell activation of B cells ; binds to epitope
12/12/1995CA1337717C Monoclonal antibodies against human necrosis factor (tnf) _ use thereof for detecting tnf in samples, and pharmaceutical compositions containing them
12/11/1995CA2151412A1 Modified guanidino and amidino thrombin inhibitors
12/07/1995WO1995033061A1 Method for introducing nucleic acid in higher eukaryotic cells
12/07/1995WO1995033060A1 Method of cancer treatment by p53 protein control
12/07/1995WO1995033050A1 Flt-4 (fms-like tyrosine-kinase), flt-15, variants thereof uses as growth factor inhibitors
12/07/1995WO1995032987A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION
12/07/1995WO1995032984A1 New lipid esters of nucleoside monophosphates and their use as immunosuppressive drugs
12/07/1995WO1995032980A1 Synthesis of oligonucleotides
12/07/1995WO1995032976A1 Polycyclic lactam derivatives for sensitizing multidrug-resistant cells to antitumour agents
12/07/1995WO1995032975A1 Indolocarbazole derivatives for sensitizing multidrug-resistant cells to antitumor agents
12/07/1995WO1995032974A1 Carbazole derivatives as agents against multi-drug resistance
12/07/1995WO1995032949A1 Gastrin and cck antagonists
12/07/1995WO1995032731A2 Immunogenic pharmaceuticals
12/07/1995WO1995032724A1 Glial mitogenic factors, their preparation and use
12/07/1995WO1995032722A1 Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof
12/07/1995WO1995024485A3 Coordinate in vivo gene expression
12/07/1995DE4435919C1 DNA encoding zinc finger protein
12/07/1995DE4418965A1 Transfection of eukaryotic cells with nucleic acid
12/07/1995CA2191762A1 Method for introducing nucleic acid in higher eukaryotic cells
12/07/1995CA2191085A1 Glial mitogenic factors, their preparation and use
12/07/1995CA2191071A1 Flt-4 (fms-like tyrosine kinase), flt-15, variants thereof used as growth factor inhibitors
12/06/1995EP0685481A2 Alkaloids from mappia foetida, the use thereof and formulations containing them
12/06/1995EP0684994A1 A novel family of anti-carcinoembryonic antigen chimeric antibodies
12/06/1995EP0684955A1 Nuclear matrix proteins
12/06/1995EP0684948A1 Meso-tetraphenyl porphyrin complex compounds, process for preparing the same and pharmaceuticals containing the same.
12/06/1995EP0684842A1 Composition for use in the treatment of tumours and the immunization of humans and animals
12/06/1995EP0684835A1 Ligand antagonists for treatment of breast cancer
1 ... 2082 2083 2084 2085 2086 2087 2088 2089 2090 2091 2092 2093 2094 2095 2096 2097 2098 2099 2100 2101 2102 ... 2211